Footwear(IN20207.HK)

Last Updated 08:00:00
longbridge loading
Company Encyclopedia
View More
name
Footwear
IN20207.HK
News
View More

07:43 ET CMUH-Ever Supreme Team Develops World-First Brain-Targeting Exosome Delivering Curcumin Across the Blood-Brain Barrier for Parkinson's Disease

China Medical University Hospital (CMUH) has announced a breakthrough in exosome-based drug delivery for Parkinson's disease, collaborating with Ever Supreme Bio Technology and Shine-On Biomedical. They developed the αDAT-EV platform, which can transport therapeutic agents across the blood-brain barrier, targeting affected neural regions. This innovation allows curcumin, known for its neuroprotective properties, to be effectively delivered to the brain. Preclinical studies show promising results in enhancing drug penetration, activating repair mechanisms, and improving motor function in animal models. The platform has potential applications in various CNS disorders and is scalable for future therapies.

prnewswire·
SH
512290
-1.45%
SZ
159992
-1.06%
SZ
159849
-1.50%
prnewswire·
SH
512290
-1.45%
SZ
159992
-1.06%
SZ
159849
-1.50%

Xtep International Holdings (XTPEF) Gets a Buy from GuoSen

GuoSen analyst has maintained a Buy rating on Xtep International Holdings (XTPEF) with a price target of HK$6.35, while the shares closed at HK$5.01. The consensus among analysts is a Strong Buy with an average target of HK$7.02, indicating a potential upside of 40.13%. Additionally, TipRanks – DeepSeek also reiterated a Buy rating with a target of HK$5.50.

Tip Ranks·
HK
01368
+0.60%
Tip Ranks·
HK
01368
+0.60%

Bank of China Reaffirms Their Buy Rating on Xtep International Holdings (XTPEF)

Bank of China has reaffirmed a Buy rating on Xtep International Holdings (XTPEF) with a price target of HK$6.50, while the shares closed at HK$5.00. Additionally, TipRanks also issued a Buy rating for Xtep, but another report from TipRanks reiterated a Hold rating on the same stock.

Tip Ranks·
HK
01368
+0.60%
Tip Ranks·
HK
01368
+0.60%

In "The Big Banks," China International Capital Corporation lowered the target price for XTEP INT'L to 6.5 yuan and maintained a "Buy" rating

Bank of China International has lowered the target price for XTEP to 6.5 yuan, maintaining a "Buy" rating. The report indicates that XTEP's core brand retail sales performance was stable last season, with the Saucony brand achieving over 30% year-on-year growth. Although the sportswear market may face pressure, XTEP is expected to achieve moderate growth through the Saucony brand. The company's earnings per share forecast for 2026 to 2027 has been revised down by 3% due to weak revenue projections for the core brand and increased spending on advertising promotions and research and development

AASTOCKS·
HK
01368
+0.60%
AASTOCKS·
HK
01368
+0.60%

Goldman Sachs has a constructive view on XTEP INT'L's brand SonyKong, maintaining a "Buy" rating

Goldman Sachs holds a constructive view on Xtep's subsidiary brand Saucony, maintaining a "Buy" rating. Xtep's main brand retail sales remained flat, while Saucony grew by 30%, in line with the 2025 guidance. Management expects to maintain a competitive advantage in the running sector and plans to enrich the outdoor product line. Goldman Sachs slightly raised its net profit forecast for 2025 by 1%, but lowered its forecasts for 2026 to 2027. UBS lowered its target price from 6.8 yuan to 6.6 yuan, maintaining a "Buy" rating

AASTOCKS·
HK
01368
+0.60%
AASTOCKS·
HK
01368
+0.60%
© 2026 Longbridge｜Disclaimer